Document Detail


Maternal serum alpha-fetoprotein screening for fetal Down syndrome in the United States: results of a survey.
MedLine Citation:
PMID:  1689959     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
To determine the status of maternal serum alpha-fetoprotein screening for fetal Down syndrome in the United States, we surveyed member laboratories in the External Quality Assessment Scheme for Pregnancy alpha-Fetoprotein in the spring of 1988. Of the 123 member laboratories that provide screening services, 109 responded. The 109 laboratories screened 586,000 pregnancies annually, and 96 provided interpretations for risk of fetal Down syndrome, accounting for 534,000 pregnancies. Numbers of women screened annually per laboratory ranged from less than 200 to greater than 27,000 (median 3000). A total of 85 of the 96 laboratories used a combination of the maternal serum alpha-fetoprotein cut-off. Ultrasonographic gestational dating was used for the initial interpretation in 25% of the screened pregnancies. The median initial positive rate (the number of women initially classified as being at increased risk) was 3.7% overall, and smaller laboratories were more likely either to have outlying initial positive rates or to be unable to provide such rates. Median initial positive rates were lower for enzyme immunoassay kits than for radioimmunoassay kits (3.0% versus 4.8%). These results indicate that, whereas most laboratories appear to perform satisfactorily in screening for fetal Down syndrome, some laboratories appear to perform satisfactorily in screening for fetal Down syndrome, some laboratories need to refine their methods of assigning risk and others need to develop mechanisms to document initial positive rates and, when appropriate, to analyze the cause of outlying initial positive rates. This survey, combined with information from nonsurveyed laboratories known to screen for fetal Down syndrome, allows an estimation that 1 million pregnancies annually were provided with fetal Down syndrome interpretations in the United States in mid-1988.
Authors:
G E Palomaki; G J Knight; M S Holman; J E Haddow
Related Documents :
20890939 - Assessment of benefits of a universal screen for maternal alcohol use during pregnancy.
15912479 - Screening for down syndrome based on maternal age or fetal nuchal translucency: a rando...
6209839 - Ultrasound screening for structural defects in early pregnancy.
11981909 - Ultrasound in prenatal diagnosis: polemics around routine ultrasound screening for seco...
3385279 - Quantitative description of subjective symptoms in pregnant women and their changes dur...
7542379 - Adverse pregnancy outcome after a false-positive screen for down syndrome using multipl...
18954239 - Pregnancy outcomes among native and foreign-born women in taiwan: maternal health utili...
1453399 - Decreased amniotic fluid index in term pregnancy. clinical significance.
7479589 - Risk-based prenatal screening for trisomy 18 using alpha-fetoprotein, unconjugated oest...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  American journal of obstetrics and gynecology     Volume:  162     ISSN:  0002-9378     ISO Abbreviation:  Am. J. Obstet. Gynecol.     Publication Date:  1990 Feb 
Date Detail:
Created Date:  1990-04-05     Completed Date:  1990-04-05     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0370476     Medline TA:  Am J Obstet Gynecol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  317-21     Citation Subset:  AIM; IM    
Affiliation:
Foundation for Blood Research, Scarborough, ME 04074.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Age Factors
Down Syndrome / diagnosis*
Female
Humans
Immunoenzyme Techniques
Pregnancy
Prenatal Diagnosis*
Reagent Kits, Diagnostic
Risk
alpha-Fetoproteins / analysis*
Chemical
Reg. No./Substance:
0/Reagent Kits, Diagnostic; 0/alpha-Fetoproteins

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  DNA polymerase alpha defect in the N syndrome.
Next Document:  Maternal serum alpha-fetoprotein levels in pregnancies among black and white women with fetal open s...